jenburkt pharmaceuticals (JBP:Mumbai)
jenburkt pharmaceuticals (JBP) Snapshot
|
Open
68.00
|
Previous Close
68.00
|
|
|
Day High
68.00
|
Day Low
68.00
|
|
|
52 Week High
07/4/12 - 82.70
|
52 Week Low
08/31/12 - 59.00
|
|
|
Market Cap
316.2M
|
Average Volume 10 Days
1.1K
|
|
|
EPS TTM
12.89
|
Shares Outstanding
4.6M
|
|
|
EX-Date
07/23/12
|
P/E TM
5.3x
|
|
|
Dividend
3.50
|
Dividend Yield
5.15%
|
Related News
jenburkt pharmaceuticals (JBP) Related Businessweek News
No Related Businessweek News Foundjenburkt pharmaceuticals (JBP) Details
Jenburkt Pharmaceuticals Ltd. engages in the manufacture and marketing of pharmaceutical formulations and healthcare products in India. It offers anti-arthritic; antibiotic; anti-diabetic; nutraceutical; anti-inflammatory analgesic; gastro intestinal; dermatological; aphrodisiac; anti-osteoporotic; anti-cough, cold, and allergy; and anti-ulcerant drugs. The company provides its products to doctors and chemist/retailers, as well as to government, semi-government institutions, missionary hospitals, and public sector enterprises. Jenburkt Pharmaceuticals Ltd. also exports its products to Asian and African countries. The company was founded in 1985 and is headquartered in Mumbai, India.
jenburkt pharmaceuticals (JBP) Top Compensated Officers
jenburkt pharmaceuticals (JBP) Key Developments
Jenburkt Pharmaceuticals Ltd. announced at its Board meeting held on February 14, 2013, has appointed Ashish U. Bhuta as Whole Time Director.
Jenburkt Pharmaceuticals Ltd. announced that the board has approved to alter the Clause V of Memorandum and Clause 5 of articles of association of the company and to alter the main object clause and other objects clause of the memorandum of association of the company at its meeting to be held on February 14, 2013.
Jenburkt Pharmaceuticals Ltd. announced that the board has recommended alteration of memorandum and articles of association of the company at its meeting to be held on February 14, 2013.
| Recently Viewed | |||
| JBP:IN | 68.00 INR | 0.00 | |
| Company | Last | Change | |
| No competitor information is available for JBP. | |||
| View Industry Companies | |||
Industry Analysis
JBP
Industry Average
| Valuation | JBP | Industry Range |
| Price/Earnings | 5.0x |
|
| Price/Sales | 0.5x |
|
| Price/Book | -- | Not Meaningful |
| Price/Cash Flow | 4.2x |
|
| TEV/Sales | -- | Not Meaningful |
Post a JobJobs
- Orlando, FL | Consult SoftPosted: May 22
- New York, NY |Posted: May 17
- San Francisco, CA | YelpPosted: May 02
- San Francisco, CA | YelpPosted: May 02
Sponsored Financial Commentaries
Sponsored Links
To contact JENBURKT PHARMACEUTICALS, please visit www.jenburkt.com. Company data is provided by Capital IQ. Please use this form to report any data issues.
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.







